{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:11:49Z","timestamp":1788315109275,"version":"build-2803163510"},"reference-count":30,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction:\u00a0Varicella zoster virus (VZV) causes infection of the central nervous system, which manifests as various neurological syndromes. In this case series, we discuss three different clinical presentations of VZV reactivation (herpes zoster). The main clinical feature of herpes zoster is a pruritic vesicular rash, present in a dermatomal distribution, which occurs after reactivation of the virus because of immunosuppression.\n\nPatients presentation:\u00a0We report on three individual cases of complicated herpes zoster that resulted in various neurological pathologies. The patients described in this case series each received a lumbar puncture with cerebrospinal fluid analysis, which showed a positive varicella zoster polymerase chain reaction test (VZV PCR).\n\nManagement and outcome:\u00a0All three patients received intravenous acyclovir as their core component of treatment. In addition to this, some received other adjunctive treatments, mainly corticosteroids. Two patients achieved disease resolution while one patient demised.\n\nConclusion:\u00a0The case series highlights the various ways in which VZV can affect the central nervous system (CNS) such as meningitis, encephalitis, myelitis and arteritis.\n\nContribution:\u00a0This is a brief overview of the clinical manifestations of VZV affecting the CNS in patients presenting to a regional hospital within the Western Cape province in South Africa.<\/jats:p>","DOI":"10.4102\/jcmsa.v2i1.76","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:43:04Z","timestamp":1720449784000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurological manifestations of Varicella zoster infection: A case series"],"prefix":"10.4102","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0747-5403","authenticated-orcid":false,"given":"Azhar","family":"Rylands","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2305-6744","authenticated-orcid":false,"given":"Shakeel","family":"Hoosain","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03p74gp79","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Cape Town"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Harper DR, Gilbert RL, Jeffries DJ. Molecular biology of varicella-zoster virus. A review prepared for the UK Advisory Group on Chickenpox. J Infect. 1998;36(suppl 1):1\u201310. https:\/\/doi.org\/10.1016\/S0163-4453(98)80149-7","DOI":"10.1016\/S0163-4453(98)80149-7"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Kennedy PGE, Gershon AA. Clinical features of Varicella-Zoster virus infection. Viruses. 2018;10(11):609. https:\/\/doi.org\/10.3390\/v10110609","DOI":"10.3390\/v10110609"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361\u2013381. https:\/\/doi.org\/10.1128\/CMR.9.3.361","DOI":"10.1128\/CMR.9.3.361"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Lizzi J, Hill T, Jakubowski J. Varicella Zoster virus Encephalitis. Clin Pract Cases Emerg Med. 2019;3(4):380\u2013382. https:\/\/doi.org\/10.5811\/cpcem.2019.8.43010","DOI":"10.5811\/cpcem.2019.8.43010"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Weinberg A, Levin MJ. VZV T cell-mediated immunity. Curr Top Microbiol Immunol. 2010;342:341\u2013357. https:\/\/doi.org\/10.1007\/82_2010_31","DOI":"10.1007\/82_2010_31"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Goswami S, Goyal R, DeLury J. A possible case of Varicella Zoster Virus (VZV) meningoencephalitis in an immunocompetent host. Cureus. 2022;14(7):e26539. https:\/\/doi.org\/10.7759\/cureus.26539","DOI":"10.7759\/cureus.26539"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sriwastava S, Kanna A, Basha O, Xu J, Yarraguntla K, George E. Varicella zoster encephalitis in an immunocompromised patient presented with migraine type headache: A case report. eNeurologicalSci. 2019 Aug 22;16:100205. https:\/\/doi.org\/10.1016\/j.ensci.2019.100205.","DOI":"10.1016\/j.ensci.2019.100205"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kennedy PG, Mogensen TH. Determinants of neurological syndromes caused by varicella zoster virus (VZV). J Neurovirol. 2020;26(4):482\u2013495. https:\/\/doi.org\/10.1007\/s13365-020-00857-w","DOI":"10.1007\/s13365-020-00857-w"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system \u2013 Prognosis, diagnostics and treatment. J Infect. 2015;71(3):281\u2013293. https:\/\/doi.org\/10.1016\/j.jinf.2015.06.004","DOI":"10.1016\/j.jinf.2015.06.004"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Persson A, Bergstr\u00f6m T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease \u2013 Viral load, clinical manifestations and sequels. J Clin Virol. 2009;46(3):249\u2013253. https:\/\/doi.org\/10.1016\/j.jcv.2009.07.014","DOI":"10.1016\/j.jcv.2009.07.014"},{"key":"ref10","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008 6;57(RR-5):1\u201330."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Chen SY, Suaya JA, Li Q, et al. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42(2):325\u2013334. https:\/\/doi.org\/10.1007\/s15010-013-0550-8","DOI":"10.1007\/s15010-013-0550-8"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"De Melker H, Berbers G, Hahn\u00e9 S, et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24(18):3946\u20133952. https:\/\/doi.org\/10.1016\/j.vaccine.2006.02.017","DOI":"10.1016\/j.vaccine.2006.02.017"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Qian J, Banks E, Macartney K, Heywood AE, Lassere MN, Liu B. Corticosteroid use and risk of Herpes Zoster in a population-based cohort. Mayo Clin Proc. 2021;96(11):2843\u20132853. https:\/\/doi.org\/10.1016\/j.mayocp.2021.05.029","DOI":"10.1016\/j.mayocp.2021.05.029"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Price NB, Grose C. Corticosteroids contribute to serious adverse events following live attenuated Varicella vaccination and live attenuated zoster vaccination. Vaccines (Basel). 2021;9(1):23. https:\/\/doi.org\/10.3390\/vaccines9010023","DOI":"10.3390\/vaccines9010023"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009;9(6):430\u2013434. https:\/\/doi.org\/10.1007\/s11910-009-0064-z","DOI":"10.1007\/s11910-009-0064-z"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ong OL, Churchyard AC, New PW. The importance of early diagnosis of herpes zoster myelitis. Med J Aust. 2010;193(9):546\u2013547. https:\/\/doi.org\/10.5694\/j.1326-5377.2010.tb04043.x","DOI":"10.5694\/j.1326-5377.2010.tb04043.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wang X, Zhang X, Yu Z, Zhang Q, Huang D, Yu S. Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients. J Neuroimmunol. 2018;321:36\u201340. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.05.005","DOI":"10.1016\/j.jneuroim.2018.05.005"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Huch JH, Cunningham AL, Arvin AM, et al. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection. J Virol. 2010;84(8):4060\u20134072. https:\/\/doi.org\/10.1128\/JVI.01450-09","DOI":"10.1128\/JVI.01450-09"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Sebastian AP, Basu A, Mitta N, Benjamin D. Transverse myelitis caused by varicella-zoster. BMJ Case Rep. 2021;14(8):e238078. https:\/\/doi.org\/10.1136\/bcr-2020-238078","DOI":"10.1136\/bcr-2020-238078"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31(8):966\u2013971. https:\/\/doi.org\/10.1212\/WNL.31.8.966","DOI":"10.1212\/WNL.31.8.966"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: Pathogenesis, diagnosis and treatment. Front Biosci. 2004;9(2):1483\u20131499. https:\/\/doi.org\/10.2741\/1351","DOI":"10.2741\/1351"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Hung CH, Chang KH, Kuo HC, et al. Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci. 2012;318(1\u20132):19\u201324. https:\/\/doi.org\/10.1016\/j.jns.2012.04.017","DOI":"10.1016\/j.jns.2012.04.017"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet. 2010;375(9716):773\u2013775. https:\/\/doi.org\/10.1016\/S0140-6736(09)61158-2","DOI":"10.1016\/S0140-6736(09)61158-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Semmler A, Hermann S, Mormann F, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38. https:\/\/doi.org\/10.1186\/1742-2094-5-38","DOI":"10.1186\/1742-2094-5-38"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Pfister D, Siegemund M, Dell-Kuster S, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12(3):R63. https:\/\/doi.org\/10.1186\/cc6891","DOI":"10.1186\/cc6891"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Shah K, Iloh N, Tabares P, Nnadi C, Sharif Z, Macaluso C. Limbic encephalitis and psychosis. Gen Hosp Psychiatry. 2013;35(6):682.e1\u2013682.e2. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.05.005","DOI":"10.1016\/j.genhosppsych.2013.05.005"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Tsau PW, Liao MF, Hsu JL. Clinical presentations and outcome studies of cranial nerve involvement in herpes zoster infection: A retrospective single-center analysis. J Clin Med. 2020;9(4):946. https:\/\/doi.org\/10.3390\/jcm9040946","DOI":"10.3390\/jcm9040946"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Gunturu M, Gosi SK, Kanduri S, Garla V. Varicella Zoster meningitis, optic neuritis preceding the development of oosterior outer retinal necrosis, and central retinal artery occlusion in a HIV patient. Case Rep Med. 2019;2019:4213162. https:\/\/doi.org\/10.1155\/2019\/4213162","DOI":"10.1155\/2019\/4213162"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: Diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731\u2013740. https:\/\/doi.org\/10.1016\/S1474-4422(09)70134-6","DOI":"10.1016\/S1474-4422(09)70134-6"}],"container-title":["Journal of the Colleges of Medicine of South Africa"],"original-title":[],"link":[{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/viewFile\/76\/175","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/viewFile\/76\/176","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/viewFile\/76\/177","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/viewFile\/76\/178","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/76\/178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:57:15Z","timestamp":1781701035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,23]]}},"URL":"https:\/\/doi.org\/10.4102\/jcmsa.v2i1.76","relation":{},"ISSN":["3105-4331","2960-110X"],"issn-type":[{"value":"3105-4331","type":"print"},{"value":"2960-110X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"article-number":"a76"}}